Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Investment analysts at William Blair raised their Q3 2024 earnings per share (EPS) estimates for shares of Astrana Health in a research report issued on Tuesday, May 7th. William Blair analyst R. Daniels now anticipates that the company will earn $0.43 per share for the quarter, up from their previous forecast of $0.41. The consensus estimate for Astrana Health's current full-year earnings is $1.65 per share. William Blair also issued estimates for Astrana Health's Q1 2025 earnings at $0.36 EPS, Q2 2025 earnings at $0.39 EPS and FY2025 earnings at $1.48 EPS.
Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $404.36 million for the quarter, compared to analysts' expectations of $413.84 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm's revenue for the quarter was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.42 EPS.
Other analysts also recently issued research reports about the company. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the stock a "hold" rating in a research note on Friday, March 1st. Stifel Nicolaus reduced their price target on Astrana Health from $50.00 to $45.00 and set a "buy" rating for the company in a report on Wednesday. Finally, Jefferies Financial Group assumed coverage on Astrana Health in a report on Monday, February 26th. They issued a "buy" rating and a $50.00 price target for the company.
Check Out Our Latest Stock Analysis on ASTH
Astrana Health Price Performance
Astrana Health stock traded up $0.96 during trading hours on Thursday, hitting $39.05. 147,609 shares of the stock traded hands, compared to its average volume of 153,958. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The firm's 50 day moving average price is $40.12. The firm has a market capitalization of $2.19 billion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. Astrana Health has a 1 year low of $28.86 and a 1 year high of $45.71.
Astrana Health Company Profile
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
